Eleven healthy live births: a result of simultaneous preimplantation genetic testing of α- and β-double thalassemia and aneuploidy screening
- 9 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Assisted Reproduction and Genetics
- Vol. 37 (3), 549-557
- https://doi.org/10.1007/s10815-020-01732-7
Abstract
Purpose To evaluate the efficacy of preimplantation genetic testing (PGT) for α- and β-double thalassemia combined with aneuploidy screening using next-generation sequencing (NGS). Methods An NGS-based PGT protocol was performed between 2017 and 2018 for twelve couples, each of which carried both α- and β-thalassemia mutations. Trophectoderm biopsy samples underwent whole-genome amplification using multiple displacement amplification (MDA), followed by NGS for thalassemia detection and aneuploidy screening. A selection of several informative single nucleotide polymorphisms (SNPs) established haplotypes. Aneuploidy screening was performed only on unaffected noncarriers and carriers. Unaffected and euploid embryos were transferred into the uterus through frozen-thawed embryo transfer (FET). Results A total of 280 oocytes were retrieved following 18 ovum pick-up (OPU) cycles, with 182 normally fertilized and 112 cultured to become blastocysts. One hundred and seven (95.5%, 107/112) blastocysts received conclusive PGT results, showing 56 (52.3%, 56/107) were unaffected. Thirty-seven (66.1%, 37/56) of the unaffected were also identified as euploid. One family had no transferable embryos. Unaffected and euploid embryos were then transferred into the uterus of the other 11 couples resulting in 11 healthy live births. The clinical pregnancy rate was 61.1% (11/18) per OPU and 68.8% (11/16) per FET, with no miscarriage reported. Seven families accepted the prenatal diagnosis and received consistent results with the NGS-based PGT. Conclusion This study indicated that NGS could realize the simultaneous PGT of double thalassemia and aneuploidy screening in a reliable and accurate manner. Moreover, it eliminated the need for multiple biopsies, alleviating the potential damages to the pre-implanted blastocysts.Keywords
Funding Information
- Guangdong Provincial Key Laboratory of Reproductive Medicine (2012A061400003)
- Guangzhou Science and Technology Project: Development and Application of The Reagents for Preimplantation Diagnosis and Screening by Next Generation Sequencing (201704020217)
This publication has 37 references indexed in Scilit:
- Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trialFertility and Sterility, 2013
- In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trialFertility and Sterility, 2013
- A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practiceJournal of Assisted Reproduction and Genetics, 2012
- One-cell biopsy significantly improves the outcome of preimplantation genetic diagnosis (PGD) treatment: retrospective analysis of 569 PGD cycles at the Stockholm PGD centreHuman Reproduction, 2012
- Development and evaluation of a reverse dot blot assay for the simultaneous detection of common alpha and beta thalassemia in ChineseBlood Cells, Molecules, and Diseases, 2011
- Preimplantation genetic diagnosis for α-and β-double thalassemiaJournal of Assisted Reproduction and Genetics, 2011
- Beta-thalassemiaGenetics in Medicine, 2010
- Preimplantation genetic diagnosis for α-thalassaemia in ChinaJournal of Assisted Reproduction and Genetics, 2009
- In Vitro Fertilization with Preimplantation Genetic ScreeningThe New England Journal of Medicine, 2007
- Simultaneous PCR detection of β – thalassemia and α – thalassemia 1 (SEA type) in prenatal diagnosis of complex thalassemia syndromeClinical Biochemistry, 2001